Cargando…

Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument

BACKGROUND: Overall survival is the ultimate criterion for the therapy of lung cancer, but psychosocial care, which helps the patient to cope with the disease, becomes a more and more important issue in the treatment of this life-threatening disease. METHODS: We report the satellite project within a...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Myriam, Gräfenstein, Laura, Karnosky, Julia, Schulz, Christian, Koller, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357622/
https://www.ncbi.nlm.nih.gov/pubmed/34393512
http://dx.doi.org/10.2147/CMAR.S314310
_version_ 1783737169128456192
author Koch, Myriam
Gräfenstein, Laura
Karnosky, Julia
Schulz, Christian
Koller, Michael
author_facet Koch, Myriam
Gräfenstein, Laura
Karnosky, Julia
Schulz, Christian
Koller, Michael
author_sort Koch, Myriam
collection PubMed
description BACKGROUND: Overall survival is the ultimate criterion for the therapy of lung cancer, but psychosocial care, which helps the patient to cope with the disease, becomes a more and more important issue in the treatment of this life-threatening disease. METHODS: We report the satellite project within a prospective, international, cross-cultural, multicenter study to validate the EORTC QLQ-LC29, a new designed module to assess the quality of life of lung cancer patients. The participants filled in the EORTC QLQ-C30, the recently updated lung cancer module QLQ-LC29 and the Hornheide questionnaire (HSI). RESULTS: A total of 81 patients (32 female and 49 male, mean age 65.2 years, SD = 9.7) were enrolled in this study by completing the questionnaires. Fatigue (mean 55.4, SD = 26.3) and dyspnea (mean 46.3, SD = 36.2) were the most prominent symptoms. Thirty-nine patients (48.1%) according to the HSI needed psychosocial support. When using the EORTC questionnaires as screening instrument with 50 as cut-off in contrast only 29.5% of our patients needed psychosocial support. The need for psychosocial support according to the HSI correlated most with the EORTC scales “fatigue” (38.3% overlap between the two questionnaires), “existential fear” (38.3% overlap between the two questionnaires) and worse “global quality of life” (27.2% overlap between the two questionnaires). CONCLUSION: If psychosocial distress is at the core, the HSI is a suitable instrument for quick screening. The EORTC measures help to specify impaired quality of life areas and also cover somatic symptoms that are specific for cancer patients. Once psychosocial distress has been ascertained, clinicians should be particularly aware of specific problems regarding “fatigue”, “existential fear” and diminished “global quality of life”. TRIAL REGISTRATION: clinicaltrials.gov, reference number NCT02745691. Registered 20 April 2016.
format Online
Article
Text
id pubmed-8357622
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-83576222021-08-13 Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument Koch, Myriam Gräfenstein, Laura Karnosky, Julia Schulz, Christian Koller, Michael Cancer Manag Res Clinical Trial Report BACKGROUND: Overall survival is the ultimate criterion for the therapy of lung cancer, but psychosocial care, which helps the patient to cope with the disease, becomes a more and more important issue in the treatment of this life-threatening disease. METHODS: We report the satellite project within a prospective, international, cross-cultural, multicenter study to validate the EORTC QLQ-LC29, a new designed module to assess the quality of life of lung cancer patients. The participants filled in the EORTC QLQ-C30, the recently updated lung cancer module QLQ-LC29 and the Hornheide questionnaire (HSI). RESULTS: A total of 81 patients (32 female and 49 male, mean age 65.2 years, SD = 9.7) were enrolled in this study by completing the questionnaires. Fatigue (mean 55.4, SD = 26.3) and dyspnea (mean 46.3, SD = 36.2) were the most prominent symptoms. Thirty-nine patients (48.1%) according to the HSI needed psychosocial support. When using the EORTC questionnaires as screening instrument with 50 as cut-off in contrast only 29.5% of our patients needed psychosocial support. The need for psychosocial support according to the HSI correlated most with the EORTC scales “fatigue” (38.3% overlap between the two questionnaires), “existential fear” (38.3% overlap between the two questionnaires) and worse “global quality of life” (27.2% overlap between the two questionnaires). CONCLUSION: If psychosocial distress is at the core, the HSI is a suitable instrument for quick screening. The EORTC measures help to specify impaired quality of life areas and also cover somatic symptoms that are specific for cancer patients. Once psychosocial distress has been ascertained, clinicians should be particularly aware of specific problems regarding “fatigue”, “existential fear” and diminished “global quality of life”. TRIAL REGISTRATION: clinicaltrials.gov, reference number NCT02745691. Registered 20 April 2016. Dove 2021-08-07 /pmc/articles/PMC8357622/ /pubmed/34393512 http://dx.doi.org/10.2147/CMAR.S314310 Text en © 2021 Koch et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Clinical Trial Report
Koch, Myriam
Gräfenstein, Laura
Karnosky, Julia
Schulz, Christian
Koller, Michael
Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument
title Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument
title_full Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument
title_fullStr Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument
title_full_unstemmed Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument
title_short Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument
title_sort psychosocial burden and quality of life of lung cancer patients: results of the eortc qlq-c30/qlq-lc29 questionnaire and hornheide screening instrument
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357622/
https://www.ncbi.nlm.nih.gov/pubmed/34393512
http://dx.doi.org/10.2147/CMAR.S314310
work_keys_str_mv AT kochmyriam psychosocialburdenandqualityoflifeoflungcancerpatientsresultsoftheeortcqlqc30qlqlc29questionnaireandhornheidescreeninginstrument
AT grafensteinlaura psychosocialburdenandqualityoflifeoflungcancerpatientsresultsoftheeortcqlqc30qlqlc29questionnaireandhornheidescreeninginstrument
AT karnoskyjulia psychosocialburdenandqualityoflifeoflungcancerpatientsresultsoftheeortcqlqc30qlqlc29questionnaireandhornheidescreeninginstrument
AT schulzchristian psychosocialburdenandqualityoflifeoflungcancerpatientsresultsoftheeortcqlqc30qlqlc29questionnaireandhornheidescreeninginstrument
AT kollermichael psychosocialburdenandqualityoflifeoflungcancerpatientsresultsoftheeortcqlqc30qlqlc29questionnaireandhornheidescreeninginstrument